医疗器械行业
- (2021-12-23)
- (2021-12-23)
- (2021-12-23)
- (2021-12-23)
- (2021-12-23)
- (2021-12-22)
新冠肺炎疫情:2.75亿!欧盟批准GSK/Vir抗体药物Xevudy(sotrovimab):单次输注可降低79%的住院/死亡风险!
(2021-12-22)- (2021-12-22)
- (2021-12-22)
- (2021-12-21)
- (2021-12-21)
- (2021-12-21)
- (2021-12-21)
- (2021-12-21)
- (2021-12-21)
- (2021-12-20)
- (2021-12-20)
- (2021-12-20)
- (2021-12-20)
- (2021-12-20)
- (2021-12-20)
- (2021-12-20)
- (2021-12-17)
- (2021-12-17)
淋巴瘤新药(DLBCL)!CD19靶向一种新的免疫增强抗体Monjuvi来那度胺:疗效优于最常用的临床方案 与CAR相当
(2021-12-17)- (2021-12-17)
- (2021-12-17)
- (2021-12-16)
- (2021-12-16)
- (2021-12-16)
- (2021-12-16)
- (2021-12-16)
- (2021-12-16)
- (2021-12-16)
- (2021-12-16)
- (2021-12-16)
- (2021-12-16)
- (2021-12-16)
- (2021-12-14)
- (2021-12-14)
- (2021-12-14)
- (2021-12-13)
- (2021-12-13)
- (2021-12-13)
- (2021-12-13)
- (2021-12-13)
- (2021-12-13)
- (2021-12-13)
- (2021-12-10)
- (2021-12-10)
- (2021-12-10)
- (2021-12-10)
- (2021-12-10)
- (2021-12-09)
来自南非医院的数据揭示了奥米克隆病毒株在新冠肺炎有多危险:病例数量正在迅速增加 显示出更年轻的年龄 但死亡率和重症率尚未上升
(2021-12-09)- (2021-12-08)
- (2021-12-08)
- (2021-12-08)
- (2021-12-08)
- (2021-12-08)